ABOUT ARO
Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases.
CENTYRIN PLATFORM
Centyrins are designed to achieve new therapeutic mechanisms by simultaneously targeting multiple cell surface receptors and delivering complex drug payloads to specific cell types and tissues.